# Disorders of Puberty: Precocious and Delayed

## Introduction

Puberty is a complex neuroendocrine process driven by reactivation of the hypothalamic-pituitary-gonadal (HPG) axis. Normal puberty begins between ages 8-13 in girls and 9-14 in boys. Precocious puberty is defined as the onset of secondary sexual characteristics before age 8 in girls or age 9 in boys. Delayed puberty is the absence of breast development by age 13 in girls or testicular enlargement by age 14 in boys. Both conditions require systematic evaluation to identify treatable underlying causes.

## Normal Pubertal Development

### Tanner Staging

| Tanner Stage | Female Breast Development | Male Genital Development | Pubic Hair (Both) |
|-------------|--------------------------|-------------------------|-------------------|
| I | Prepubertal | Prepubertal testes (<4 mL) | None |
| II | Breast bud | Testes 4-8 mL, scrotal thinning | Sparse, fine hair at base |
| III | Breast elevation beyond areola | Testes 8-12 mL, penile lengthening | Darker, curling, spread |
| IV | Areola forms secondary mound | Testes 12-15 mL, penile broadening | Adult-type, limited area |
| V | Adult contour | Adult testes (>15 mL) | Adult distribution |

In girls, breast development (thelarche) is typically the first sign; menarche occurs approximately 2-2.5 years after thelarche, usually at Tanner stage IV. In boys, testicular enlargement to 4 mL or greater (or greater than 2.5 cm in longest diameter) marks the onset of puberty, with peak height velocity occurring at Tanner stage III-IV. Adrenarche, the increase in adrenal androgen production (DHEA-S), occurs independently and causes axillary and pubic hair, body odor, and acne. This is distinct from gonadal puberty.

### Hormonal Cascade

GnRH from the hypothalamus stimulates pituitary release of LH and FSH. LH drives gonadal steroid production (estradiol in girls, testosterone in boys), while FSH promotes folliculogenesis and spermatogenesis. Pulsatile GnRH secretion initially occurs during sleep and becomes sustained as puberty progresses.

## Precocious Puberty

### Central Precocious Puberty (CPP) -- GnRH-Dependent

Central precocious puberty results from premature activation of the HPG axis. In girls, it is more common (female-to-male ratio of 10:1) and the majority (80-90%) are idiopathic. In boys, there is a higher likelihood of underlying pathology, with CNS lesions found in up to 50% of cases. Causes include idiopathic, CNS tumors (hypothalamic hamartoma, optic glioma), hydrocephalus, CNS infection, head trauma, prior cranial radiation, and neurofibromatosis type 1.

### Peripheral Precocious Puberty (PPP) -- GnRH-Independent

Peripheral precocious puberty results from sex steroid production independent of the HPG axis. In girls, causes include ovarian cysts or tumors, McCune-Albright syndrome, and exogenous estrogen exposure. In boys, causes include congenital adrenal hyperplasia, adrenal tumors, Leydig cell tumors, hCG-secreting tumors (hepatoblastoma, germinoma), McCune-Albright syndrome, and familial male-limited precocious puberty (testotoxicosis).

### Evaluation of Precocious Puberty

The history should assess timing and progression of sexual characteristics, growth velocity, and exposure to exogenous hormones. Physical examination includes Tanner staging, testicular size (bilateral enlargement suggests CPP; unilateral suggests tumor), and skin findings (cafe-au-lait spots in McCune-Albright or NF1). Laboratory evaluation includes LH, FSH (basal and GnRH-stimulated), estradiol, testosterone, DHEA-S, 17-hydroxyprogesterone, thyroid function, and beta-hCG. The GnRH stimulation test showing an LH-predominant response confirms CPP. Bone age is advanced in true precocious puberty. Brain MRI with focus on the hypothalamic-pituitary region is mandatory in all boys with CPP and girls under 6 years with CPP. Pelvic ultrasound evaluates ovarian and uterine size and pathology in girls.

<image>Comparison diagram of central vs peripheral precocious puberty showing the HPG axis, with central pathway activated at the hypothalamic level and peripheral pathway showing autonomous gonadal or adrenal steroid production bypassing hypothalamic control</image>

### Treatment

Central precocious puberty is treated with GnRH agonists (leuprolide, histrelin implant), which suppress the HPG axis, halt pubertal progression, slow bone age advancement, and improve predicted adult height. Peripheral precocious puberty requires treatment of the underlying cause (surgical resection of tumors, aromatase inhibitors, anti-androgens, ketoconazole). Monitoring includes growth velocity, Tanner staging, bone age, and hormone levels every 3-6 months.

## Delayed Puberty

### Etiology

Constitutional delay of growth and puberty (CDGP) is the most common cause. It follows a familial pattern of late puberty with delayed bone age, and normal adult height is typically achieved. Hypogonadotropic hypogonadism (central or functional causes) includes Kallmann syndrome (anosmia plus GnRH deficiency), pituitary tumors (craniopharyngioma, prolactinoma), chronic illness (IBD, celiac disease, cystic fibrosis), eating disorders, excessive exercise, severe stress, and hypothalamic or pituitary radiation. Hypergonadotropic hypogonadism (gonadal failure) includes Turner syndrome (45,X) in girls, Klinefelter syndrome (47,XXY) in boys, gonadal dysgenesis, chemotherapy- or radiation-induced gonadal damage, and autoimmune gonaditis.

### Evaluation

The history should cover growth pattern, family pubertal timing, chronic illness, medication use, nutritional status, and anosmia. Physical examination includes Tanner staging, body proportions, and dysmorphic features (webbed neck and shield chest in Turner syndrome; eunuchoid proportions). Laboratory testing includes LH and FSH (elevated in gonadal failure; low or normal in central or constitutional causes), estradiol or testosterone, prolactin, TSH, free T4, IGF-1, CBC, ESR, and celiac panel. Bone age is delayed in CDGP and central causes. Karyotype should be obtained if gonadal failure is suspected (Turner, Klinefelter). Brain MRI is indicated if central hypogonadism is suspected.

<image>Diagnostic algorithm for delayed puberty showing initial assessment with LH/FSH levels branching into hypergonadotropic (elevated gonadotropins, gonadal failure) and hypogonadotropic (low gonadotropins, central causes vs constitutional delay) pathways with associated etiologies and workup</image>

### Treatment

For constitutional delay, reassurance and observation are appropriate. A short course of low-dose sex steroids may be offered to initiate puberty and provide psychosocial benefit: testosterone enanthate 50-100 mg IM monthly for 3-6 months in boys, or low-dose estradiol (oral or transdermal) with slow titration in girls. For hypogonadotropic hypogonadism, sex steroid replacement is used to induce puberty, with pulsatile GnRH or gonadotropins available for fertility induction later. For hypergonadotropic hypogonadism, sex steroid replacement therapy is used for puberty induction and long-term maintenance, with fertility counseling provided.

<image>Timeline illustration showing normal pubertal milestones for boys and girls with Tanner staging, highlighting age cutoffs for precocious and delayed puberty definitions</image>

## Clinical Pearls

Premature thelarche (isolated breast development without other pubertal signs or accelerated growth) is usually benign and self-limited but requires monitoring. Any boy with central precocious puberty needs a brain MRI regardless of age. Constitutional delay is a diagnosis of exclusion, and chronic illness, hypothyroidism, celiac disease, and eating disorders must always be ruled out. Turner syndrome should be suspected in any girl with delayed puberty, short stature, or primary amenorrhea, and a karyotype should be obtained. The psychosocial impact of pubertal disorders is significant, and emotional well-being should be addressed alongside medical management.

## References
1. Carel JC, Leger J. Precocious Puberty. *N Engl J Med*. 2008;358(22):2366-2377.
2. Palmert MR, Dunkel L. Delayed Puberty. *N Engl J Med*. 2012;366(5):443-453.
3. Kaplowitz PB. Precocious Puberty: Update on Secular Trends, Definitions, Diagnosis, and Treatment. *Adv Pediatr*. 2004;51:37-62.
4. Styne DM, Grumbach MM. Physiology and Disorders of Puberty. In: *Williams Textbook of Endocrinology*. 14th ed. Elsevier; 2020.